Shopping Cart
- Remove All
- Your shopping cart is currently empty
Elgodipine significantly reduced the incidence and severity of exercise-induced angina pectoris systemically and was able to inhibit vascular smooth muscle proliferation through a mechanism independent of the expression of the transcription factors c-fos and c-jun. The Elgodipine-induced inhibition was voltage-dependent. Elgodipine is a potential compound for the treatment of angina pectoris.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $128 | In Stock | |
5 mg | $320 | In Stock | |
10 mg | $470 | In Stock | |
25 mg | $772 | In Stock | |
50 mg | $1,080 | In Stock | |
100 mg | $1,460 | In Stock | |
500 mg | $2,920 | In Stock |
Description | Elgodipine significantly reduced the incidence and severity of exercise-induced angina pectoris systemically and was able to inhibit vascular smooth muscle proliferation through a mechanism independent of the expression of the transcription factors c-fos and c-jun. The Elgodipine-induced inhibition was voltage-dependent. Elgodipine is a potential compound for the treatment of angina pectoris. |
Targets&IC50 | Ca2+ channel:0.33 µM |
In vivo | Elgodipine (64 micrograms/kg; i.v.; 22 patients) significantly decreased systemic vascular resistance as well as systolic and diastolic blood pressure, while increasing cardiac output and stroke volume. Heart rate was not affected by elgodipine, either at rest or during exercise.[1] |
Molecular Weight | 524.58 |
Formula | C29H33FN2O6 |
Cas No. | 119413-55-7 |
Smiles | C(OCCN(CC1=CC=C(F)C=C1)C)(=O)C=2C(C(C(OC(C)C)=O)=C(C)NC2C)C3=C4C(=CC=C3)OCO4 |
Storage | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 55 mg/mL (104.85 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.